Sarah Thayer

Ms. Thayer brings more than 20 years of progressive leadership experience in clinical development operations across various therapeutic areas including oncology, cardiovascular, immunology, ophthalmology, and central nervous system disorders from Phase 1 through Phase 3. Prior to joining Ashvattha, she served as Vice President, Head of Clinical Operations at Recode Therapeutics where she established the clinical operations function at the company. Previously, she led clinical operations at Global Blood Therapeutics (Pfizer), StemCells Inc, FivePrime Therapeutics (Amgen), CV Therapeutics (Gilead), Titan Pharmaceuticals and Becton Dickinson Immunocytometry Systems. Ms. Thayer earned her B.S. in Molecular, Cellular, and Development Biology from The University of Colorado Boulder and completed an undergraduate research fellowship at the Laboratory of Host Defenses, NIAD.